Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Managers’ transactions


Posted on: 03 Nov 17

BioPorto A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.

 

1 Details of the person discharging managerial responsibilities/person closely associated

 

 
a) Name Thomas Magnussen
2 Reason for the notification  
a) Position/status Chairman of the Board
b) Initial notification/Amendment Initial notification
3 Details of the issuer  
a) Name BioPorto A/S
b) LEI 5299004SWFL5JAN4W830
4 Details of the transaction(s)  
a) Description of the financial instrument, type of instrument
Identification code
Shares
ISIN: DK0011048619
b) Nature of the transaction Subscription in connection with a private placement
c) Price(s) and volume(s) Price: DKK 3.20, Volume: 312,500
d) Aggregated information n/a
 
e) Date of the transaction 2017-11-03
f) Place of the transaction Outside a trading venue

 

For further information please contact:

Peter Mørch Eriksen, CEO

Gry Husby Larsen, Investor relations

Tel.: 45 29 00 00, e-mail investor@bioporto.com

GlobeNewswire
globenewswire.com

Last updated on: 06/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.